A Phase I Study of SB939 in Pediatric Patients With Refractory Solid Tumours and Leukemia

NCT01184274 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

NETWORK

Sponsor class

Conditions

Leukemia
Solid Tumours

Interventions

DRUG: SB939

Sponsor

NCIC Clinical Trials Group

Collaborators

[object Object]